Showing items 1–100
HPV-specific binding molecules
Grant US-11952408-B2
United States of America
Increasing specificity for RNA-guided genome editing
Grant US-11920152-B2
United States of America
Compositions for linking DNA-binding domains and cleavage domains
Grant US-11920169-B2
United States of America
RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
Application WO-2024033901-A1
World Intellectual Property Organisation (WIPO)
Systems and methods for the treatment of hemoglobinopathies
Grant US-11851690-B2
United States of America
NOVEL CAS EFFECTOR PROTEIN, GENE EDITING SYSTEM, AND USE
Application WO-2023227028-A1
World Intellectual Property Organisation (WIPO)
Engineered target specific nucleases
Grant US-11827900-B2
United States of America
Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
Grant US-11820728-B2
United States of America
Human application of engineered chimeric antigen receptor (CAR) T-cells
Grant US-11786582-B2
United States of America
TYPE II CRISPR/CAS9 GENOME EDITING SYSTEM AND THE APPLICATION THEREOF
Application EP-4230734-A1
European Patent Office
Lipid nanoparticle formulations
Grant US-11712481-B2
United States of America
RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
Application WO-2023139557-A1
World Intellectual Property Organisation (WIPO)
Genetic modification of cytokine inducible SH2-containing protein (CISH) gene
Grant US-11661611-B2
United States of America
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
Grant US-11648324-B2
United States of America
Lipids for use in lipid nanoparticle formulations
Grant US-11639329-B2
United States of America
Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome…
Grant US-11634731-B2
United States of America
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
Grant US-11634379-B2
United States of America
Compositions and methods for treating CEP290 associated disease
Grant US-11566263-B2
United States of America
Lipids for use in lipid nanoparticle formulations
Grant US-11542225-B2
United States of America
Lipids for use in lipid nanoparticle formulations
Grant US-11524932-B2
United States of America
Systems and methods for treating alpha 1-antitrypsin (A1AT) deficiency
Grant US-11512311-B2
United States of America
NOVEL CRISPR ENZYMES, METHODS, SYSTEMS AND USES THEREOF
Application WO-2022204268-A3
World Intellectual Property Organisation (WIPO)
Compositions and methods for the treatment of hemoglobinopathies
Grant US-11466271-B2
United States of America
Lipids for lipid nanoparticle delivery of active agents
Grant US-11453639-B2
United States of America
DNA-CUTTING AGENT
Application EP-3889270-A4
European Patent Office
Delivery, use and therapeutic applications of the CRISPR-Cas systems and compositions for…
Grant US-11407985-B2
United States of America
Lipids for delivery of active agents
Grant US-11357856-B2
United States of America
Targeted disruption of the T cell receptor
Grant US-11352631-B2
United States of America
Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
Grant US-11344577-B2
United States of America
Compositions and methods for treating CEP290-associated disease
Grant US-11339437-B2
United States of America
Targeted disruption of the MHC cell receptor
Grant US-11285175-B2
United States of America
CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (L…
Grant US-11268086-B2
United States of America
CRISPR/CAS-related methods and compositions for treating sickle cell disease
Grant US-11242525-B2
United States of America
Methods and compositions for the treatment of Fabry disease
Grant US-11219695-B2
United States of America
Lentiviral protein delivery system for RNA-guided genome editing
Grant US-11203768-B2
United States of America
Evaluation of Cas9 molecule/guide RNA molecule complexes
Grant US-11180793-B2
United States of America
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic…
Grant US-11168338-B2
United States of America
CRISPR-Cas systems, crystal structure and uses thereof
Grant US-11155795-B2
United States of America
CRISPR-Cas systems and methods for altering expression of gene products, structural…
Grant US-11149259-B2
United States of America
Functional genomics using CRISPR-Cas systems, compositions, methods, screens and…
Grant US-11149267-B2
United States of America
Compositions and methods for treating CEP290-associated disease
Grant US-11141493-B2
United States of America
Htt repressors and uses thereof
Grant US-11123443-B2
United States of America
Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome…
Grant US-11098326-B2
United States of America
Engineered CRISPR-Cas9 nucleases
Grant US-11060078-B2
United States of America
Delivery, engineering and optimization of systems, methods and compositions for sequence…
Grant US-11041173-B2
United States of America
CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis…
Grant US-11028388-B2
United States of America
Engineered target specific nucleases
Grant US-10975393-B2
United States of America
Modulation of liver genes
Grant US-10960085-B2
United States of America
Methods, models, systems, and apparatus for identifying target sequences for Cas enzymes…
Grant US-10930367-B2
United States of America
Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disorders
Grant US-10851357-B2
United States of America
Increasing specificity for RNA-guided genome editing
Grant US-10844403-B2
United States of America
PHAGE RESISTANT LACTIC ACID BACTERIA
Grant EP-3172315-B1
European Patent Office
Functional genomics using CRISPR-Cas systems, compositions, methods, screens and…
Grant US-10781444-B2
United States of America
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic…
Grant US-10760064-B2
United States of America
Compositions for linking DNA-binding domains and cleavage domains
Grant US-10724020-B2
United States of America
CRISPR enzymes and systems
Grant US-10669540-B2
United States of America
Engineered CRISPR-Cas9 nucleases
Grant US-10633642-B2
United States of America
Delivery and use of the CRISPR-Cas systems, vectors and compositions for hepatic…
Grant US-10577630-B2
United States of America
Polynucleotide amplification using CRISPR-Cas systems
Grant US-10577649-B2
United States of America
Systems, methods and compositions for sequence manipulation with optimized functional…
Grant US-10550372-B2
United States of America
Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome…
Grant US-10544433-B2
United States of America
Engineered CRISPR-Cas9 nucleases
Grant US-10526591-B2
United States of America
Multiplex guide RNAs
Grant US-10526589-B2
United States of America
Modified polynucleotides
Grant US-10501512-B2
United States of America
Targeted disruption of the MHC cell receptor
Application US-10500229-B2
United States of America
Genetically modified human cell with a corrected mutant sickle cell mutation
Grant US-10435677-B2
United States of America
Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome…
Grant US-10415059-B2
United States of America
CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
Grant US-10391126-B2
United States of America
CRISPR-CAS systems and methods for altering expression of gene products, structural…
Application US-10377998-B2
United States of America
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic…
Grant US-10378027-B2
United States of America
Amelioration of chronic kidney disease
Grant US-10377801-B2
United States of America
CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (L…
Grant US-10253312-B2
United States of America
Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome…
Grant US-10138476-B2
United States of America
Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome…
Grant US-10119133-B2
United States of America
Engineered CRISPR-Cas9 nucleases
Grant US-10093910-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-10064959-B2
United States of America
Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome…
Grant US-10011850-B2
United States of America
Method of treating lysosomal storage diseases
Grant US-9956247-B2
United States of America
Nuclease-mediated regulation of gene expression
Grant US-9957501-B2
United States of America
Delivery and formulation of engineered nucleic acids
Grant US-9950068-B2
United States of America
CRISPR/CAS-related methods and compositions for treating leber's congenital amaurosis 10 (L…
Grant US-9938521-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9937233-B2
United States of America
Engineered CRISPR-Cas9 nucleases
Grant US-9926546-B2
United States of America
Increasing specificity for RNA-guided genome editing
Grant US-9885033-B2
United States of America
Modified polynucleotides for the production of cosmetic proteins and peptides
Grant US-9878056-B2
United States of America
CRISPR-Cas component systems, methods and compositions for sequence manipulation
Grant US-9840713-B2
United States of America
Modified polynucleotides for the production of secreted proteins
Grant US-9828416-B2
United States of America
Modified polynucleotides for the production of proteins
Grant US-9827332-B2
United States of America
CRISPR-Cas component systems, methods and compositions for sequence manipulation
Grant US-9822372-B2
United States of America
Modified polynucleotides for the production of biologics and proteins associated with…
Grant US-9814760-B2
United States of America
Tagged microorganisms and methods of tagging
Grant US-9816140-B2
United States of America
Modified polynucleotides for the production of proteins associated with human disease
Grant US-9782462-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9701965-B2
United States of America
Anti-CD19 scFv (FMC63) polypeptide
Grant US-9701758-B2
United States of America
Modified polynucleotides encoding hepatitis A virus cellular receptor 2
Grant US-9675668-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-9657295-B2
United States of America
Human application of engineered chimeric antigen receptor (CAR) T-cells
Grant US-9629877-B2
United States of America
Terminally modified RNA
Grant US-9597380-B2
United States of America
Modified polynucleotides for the production of oncology-related proteins and peptides
Grant US-9587003-B2
United States of America
Showing items 1–100